Spots Global Cancer Trial Database for stage iii colon cancer
Every month we try and update this database with for stage iii colon cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Cytokine-induced Killer Cell Immunotherapy for Surgical Resected Stage III Colorectal Cancer Patients After Chemotherapy | NCT02280278 | Stage III Colon... | Radical surgery Adjuvant chemot... Cytokine-induce... | 18 Years - 70 Years | Sun Yat-sen University | |
Combination Chemotherapy With or Without Bevacizumab Compared With Bevacizumab Alone in Treating Patients With Advanced or Metastatic Colorectal Cancer That Has Been Previously Treated | NCT00025337 | Adenocarcinoma ... Adenocarcinoma ... Recurrent Colon... Recurrent Recta... Stage III Colon... Stage III Recta... Stage IV Colon ... Stage IV Rectal... | bevacizumab oxaliplatin leucovorin calc... fluorouracil | 18 Years - | National Cancer Institute (NCI) | |
Sorafenib, Cetuximab, and Irinotecan in Treating Patients With Advanced or Metastatic Colorectal Cancer | NCT00134069 | Recurrent Colon... Recurrent Recta... Stage III Colon... Stage III Recta... Stage IV Colon ... Stage IV Rectal... | sorafenib tosyl... cetuximab irinotecan hydr... | 18 Years - | National Cancer Institute (NCI) | |
Combination Chemotherapy and Cetuximab as First-Line Therapy in Treating Patients With Advanced and/or Metastatic Colorectal Cancer | NCT00640081 | Colorectal Canc... | cetuximab capecitabine fluorouracil leucovorin calc... oxaliplatin immunohistochem... laboratory biom... | 18 Years - 100 Years | Medical Research Council | |
Gemcitabine in Treating Patients With Advanced Colorectal Cancer | NCT00007943 | Colorectal Canc... | gemcitabine hyd... | 18 Years - 120 Years | Wake Forest University Health Sciences | |
Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer | NCT00005842 | Cancer | trastuzumab tipifarnib | 18 Years - | National Cancer Institute (NCI) | |
Cetuximab and Irinotecan in Treating Patients With Advanced Colorectal Cancer | NCT00005076 | Colorectal Canc... | cetuximab irinotecan hydr... | 18 Years - | University of Alabama at Birmingham | |
Chemotherapy With Raltitrexed and Fluorouracil in Treating Patients With Advanced Colorectal Cancer | NCT00002828 | Colorectal Canc... | fluorouracil raltitrexed | 18 Years - | Memorial Sloan Kettering Cancer Center | |
Combination Chemotherapy in Treating Patients With Colorectal Cancer | NCT00006103 | Colorectal Canc... | fluorouracil irinotecan hydr... leucovorin calc... | - | Alliance for Clinical Trials in Oncology | |
Immunotherapy With CEA(6D) VRP Vaccine (AVX701) in Patients With Stage III Colorectal Cancer | NCT01890213 | Stage III Colon... | AVX701 | 18 Years - | Duke University | |
Combination Chemotherapy and Radiation Therapy in Treating Patients With Colorectal Cancer | NCT00002801 | Colorectal Canc... | leucovorin calc... tegafur-uracil radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
High-Dose Fluorouracil With or Without Leucovorin Compared With Standard Fluorouracil Plus Leucovorin Following Surgery in Treating Patients With Stage III Colon Cancer | NCT00004150 | Colorectal Canc... | fluorouracil leucovorin calc... adjuvant therap... | 18 Years - | National Cancer Institute (NCI) | |
SU5416 in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer | NCT00006001 | Colorectal Canc... | semaxanib | 18 Years - | National Cancer Institute (NCI) | |
Fluorouracil and Leucovorin With or Without Irinotecan in Treating Patients Following Surgery for Stage III Colorectal Cancer | NCT00026273 | Colorectal Canc... | FOLFIRI regimen fluorouracil irinotecan hydr... leucovorin calc... | 18 Years - 75 Years | Pfizer | |
Suberoylanilide Hydroxamic Acid, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Progressive Metastatic or Unresectable Colorectal Cancer or Other Solid Tumors | NCT00138177 | Recurrent Colon... Recurrent Recta... Stage III Colon... Stage III Recta... Stage IV Colon ... Stage IV Rectal... Unspecified Adu... | oxaliplatin leucovorin calc... vorinostat fluorouracil | 18 Years - | National Cancer Institute (NCI) | |
GM-CSF and Combination Chemotherapy in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Colon Cancer | NCT00262808 | Colorectal Canc... | sargramostim fluorouracil leucovorin calc... oxaliplatin adjuvant therap... conventional su... neoadjuvant the... | 18 Years - | University of Rochester | |
Biomarker-Guided Fluorouracil in Treating Patients With Colorectal Cancer Receiving Combination Chemotherapy | NCT01164215 | Colorectal Canc... Diarrhea Neutropenia | fluorouracil leucovorin oxaliplatin | - | UNC Lineberger Comprehensive Cancer Center | |
Sorafenib, Cetuximab, and Irinotecan in Treating Patients With Advanced or Metastatic Colorectal Cancer | NCT00134069 | Recurrent Colon... Recurrent Recta... Stage III Colon... Stage III Recta... Stage IV Colon ... Stage IV Rectal... | sorafenib tosyl... cetuximab irinotecan hydr... | 18 Years - | National Cancer Institute (NCI) | |
Biological Therapy With Combination Chemotherapy in Patients With Colorectal Cancer | NCT00003063 | Colorectal Canc... | recombinant int... fluorouracil leucovorin calc... levamisole hydr... | - 75 Years | National Cancer Institute (NCI) | |
Lymphatic Mapping and Sentinel Lymph Node Biopsy in the Treatment of Colorectal Cancer | NCT00005640 | Colorectal Canc... | Preoperative En... Technetium Tc 9... Gamma Probe Biopsy of Senti... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
Vaccine Therapy in Treating Patients With Stage II or Stage III Colon Cancer That Has Been Removed During Surgery | NCT00016133 | Colorectal Canc... | BCG vaccine autologous tumo... fluorouracil leucovorin calc... adjuvant therap... | 21 Years - 85 Years | National Cancer Institute (NCI) | |
Fluorouracil and Oxaliplatin With or Without Panitumumab In Treating Patients With High-Risk Colon Cancer That Can Be Removed by Surgery | NCT00647530 | Colorectal Canc... | panitumumab capecitabine fluorouracil oxaliplatin | 18 Years - | University of Birmingham | |
Moderate Physical Activity in Helping Patients Recover Physically and Emotionally From Stage II Or Stage III Colorectal Cancer | NCT00373022 | Anxiety Disorde... Colorectal Canc... Depression Psychosocial Ef... | exercise interv... flow cytometry laboratory biom... management of t... psychosocial as... quality-of-life... | 18 Years - | University of Arizona | |
Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy | NCT00048971 | Colorectal Canc... Diarrhea Neutropenia | mutation analys... polymorphic mic... | 18 Years - | Alliance for Clinical Trials in Oncology | |
Combination Chemotherapy and Cetuximab as First-Line Therapy in Treating Patients With Advanced and/or Metastatic Colorectal Cancer | NCT00640081 | Colorectal Canc... | cetuximab capecitabine fluorouracil leucovorin calc... oxaliplatin immunohistochem... laboratory biom... | 18 Years - 100 Years | Medical Research Council | |
OSI-7904L and Oxaliplatin in Treating Patients With Refractory or Recurrent Advanced Colorectal Cancer | NCT00081237 | Colorectal Canc... | OSI-7904L oxaliplatin | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
Genetic Study in Patients With Stage II or Stage III Colon Cancer | NCT00003833 | Colorectal Canc... | DNA stability a... gene mapping | - 69 Years | Alliance for Clinical Trials in Oncology | |
Genetic Study of Young Patients With Colorectal Cancer | NCT00044967 | Colorectal Canc... | microsatellite ... | 18 Years - 49 Years | Alliance for Clinical Trials in Oncology | |
Dose Dense Therapy and Bevacizumab in Solid Tumors and Colorectal Cancer | NCT00296062 | Colorectal Canc... Unspecified Adu... | bevacizumab capecitabine irinotecan hydr... oxaliplatin | 18 Years - | Case Comprehensive Cancer Center | |
Disease Management Program or Usual Care in Patients With Stage III or Stage IV Lung Cancer, Pancreatic Cancer, Ovarian Cancer, or Colorectal Cancer, and Their Caregivers | NCT00684801 | Colorectal Canc... Lung Cancer Ovarian Cancer Pancreatic Canc... | questionnaire a... quality-of-life... | 18 Years - | Case Comprehensive Cancer Center | |
Fluorouracil Plus Leucovorin With or Without Oxaliplatin in Treating Patients With Stage II or Stage III Colon Cancer | NCT00004931 | Stage II Colon ... Stage III Colon... | leucovorin calc... fluorouracil oxaliplatin laboratory biom... | - | National Cancer Institute (NCI) | |
Genetic Study of Patients and Families With a History of Colorectal Cancer | NCT00003648 | Colorectal Canc... | DNA stability a... gene rearrangem... | - | Alliance for Clinical Trials in Oncology | |
Lymphatic Mapping, Sentinel Lymph Node Analysis, and Blood Tests in Detecting and Predicting Early Micrometastases in Patients With Colorectal Cancer | NCT00625625 | Colorectal Canc... | isosulfan blue polymerase chai... diagnostic labo... immunohistochem... diagnostic lymp... therapeutic con... therapeutic lym... | 18 Years - | National Cancer Institute (NCI) | |
Oxaliplatin, Irinotecan, and Capecitabine in Treating Patients With Advanced or Metastatic Colorectal Cancer That Cannot Be Removed By Surgery | NCT00217711 | Colorectal Canc... | Capecitabine irinotecan hydr... oxaliplatin | 18 Years - 70 Years | Swiss Group for Clinical Cancer Research | |
Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery | NCT00004895 | Colorectal Canc... Constipation, I... Extrahepatic Bi... Gastric Cancer Gastrointestina... Nausea and Vomi... Ovarian Cancer Pancreatic Canc... Peritoneal Cavi... Small Intestine... | octreotide acet... | 18 Years - | Northwestern University | |
Leucovorin and Fluorouracil Compared With Observation in Treating Patients With Colorectal Cancer That Has Been Surgically Removed | NCT00005586 | Colorectal Canc... | L-leucovorin fluorouracil adjuvant therap... | 18 Years - | National Cancer Institute (NCI) | |
Combination Chemotherapy With or Without Cetuximab in Treating Patients With Stage III Colon Cancer That Was Completely Removed By Surgery | NCT00265811 | Colorectal Canc... | Folfox Cetuximab | 18 Years - 74 Years | Federation Francophone de Cancerologie Digestive | |
Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Gastrointestinal Cancer | NCT00025532 | Colorectal Canc... Esophageal Canc... Gastric Cancer Pancreatic Canc... | iodine I 131 mo... | 19 Years - | University of California, San Francisco | |
Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer | NCT00002475 | Breast Cancer Colorectal Canc... Kidney Cancer Lung Cancer Malignant Mesot... Pancreatic Canc... | allogeneic tumo... autologous tumo... recombinant int... recombinant int... sargramostim cyclophosphamid... | 18 Years - | National Cancer Institute (NCI) | |
Fluorouracil, Semustine, and Vincristine Compared With BCG in Treating Patients With Dukes' B or Dukes' C Colon Cancer That Has Been Removed By Surgery | NCT00427570 | Colorectal Canc... | BCG vaccine biological ther... fluorouracil semustine vincristine sul... | - 79 Years | National Cancer Institute (NCI) | |
Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC) | NCT01126346 | Advanced Malign... Carcinoma of th... Ovarian Sarcoma Ovarian Stromal... Pseudomyxoma Pe... Recurrent Colon... Recurrent Malig... Recurrent Ovari... Recurrent Ovari... Stage III Colon... Stage III Ovari... Stage III Ovari... Stage IV Colon ... Stage IV Ovaria... Stage IV Ovaria... Unspecified Chi... | HIPEC Orientati... Consultation wi... Questionnaires | - | Wake Forest University Health Sciences | |
A Phase I/II Study With CEA(6D) VRP Vaccine in Patients With Advanced or Metastatic CEA-Expressing Malignancies | NCT00529984 | Colorectal Canc... Breast Cancer Lung Cancer Pancreatic Canc... Colon Cancer | AVX701 AVX701 AVX701 AVX701 AVX701 | 18 Years - | AlphaVax, Inc. | |
Radiation Therapy Plus Irinotecan in Treating Patients With Colon Cancer | NCT00003344 | Colorectal Canc... | irinotecan hydr... radiation thera... | 18 Years - 120 Years | Medical University of South Carolina | |
Combination Chemotherapy for 3 Months or 6 Months in Treating Patients With Stage III Colon Cancer | NCT00958737 | Colorectal Canc... | FOLFOX regimen CAPOX | 18 Years - | GERCOR - Multidisciplinary Oncology Cooperative Group | |
Study of Tumor Samples From Patients With Stage III Colon Cancer Who Have Undergone Surgery and Chemotherapy | NCT00918827 | Colorectal Canc... | - | Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan | ||
Standard Therapy With or Without Surgery and Mitomycin C in Treating Patients With Advanced Limited Peritoneal Dissemination of Colon Cancer | NCT01167725 | Colorectal Canc... | bevacizumab cetuximab FOLFIRI regimen FOLFOX regimen capecitabine fluorouracil irinotecan hydr... leucovorin calc... mitomycin C oxaliplatin therapeutic con... | 18 Years - | National Cancer Institute (NCI) | |
Resveratrol in Treating Patients With Colorectal Cancer That Can Be Removed By Surgery | NCT00433576 | Adenocarcinoma ... Adenocarcinoma ... Stage I Colon C... Stage I Rectal ... Stage II Colon ... Stage II Rectal... Stage III Colon... Stage III Recta... | resveratrol pharmacological... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
Making Decisions About Participating in a Cancer Clinical Trial for Patients With Stage II, Stage III, or Stage IV Pancreatic Cancer or Stage III or Stage IV Colon Cancer or Rectal Cancer | NCT00478010 | Colorectal Canc... Pancreatic Canc... Psychosocial Ef... | counseling inte... study of socioe... psychosocial as... quality-of-life... | 18 Years - 120 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC) | NCT01126346 | Advanced Malign... Carcinoma of th... Ovarian Sarcoma Ovarian Stromal... Pseudomyxoma Pe... Recurrent Colon... Recurrent Malig... Recurrent Ovari... Recurrent Ovari... Stage III Colon... Stage III Ovari... Stage III Ovari... Stage IV Colon ... Stage IV Ovaria... Stage IV Ovaria... Unspecified Chi... | HIPEC Orientati... Consultation wi... Questionnaires | - | Wake Forest University Health Sciences | |
Differences in Timely Cancer Diagnosis in African American and Caucasian Patients With Newly Diagnosed Colorectal Cancer | NCT00856115 | Colorectal Canc... | medical chart r... questionnaire a... study of socioe... survey administ... | 21 Years - | Case Comprehensive Cancer Center | |
Follow-Up Study of Patients Who Have Undergone Surgery for Stage I, Stage II, or Stage III Colorectal Cancer | NCT00560365 | Colorectal Canc... | laboratory biom... computed tomogr... magnetic resona... quality-of-life... | 50 Years - | National Cancer Institute (NCI) | |
Massage Therapy in Treating the Symptoms of Patients With Locally Advanced or Metastatic Cancer | NCT00253708 | Cancer | management of t... massage therapy pain therapy psychosocial as... quality-of-life... | 18 Years - 120 Years | Beth Israel Deaconess Medical Center | |
Gemcitabine in Treating Patients With Advanced Colorectal Cancer | NCT00007943 | Colorectal Canc... | gemcitabine hyd... | 18 Years - 120 Years | Wake Forest University Health Sciences | |
Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors | NCT00089362 | Male Breast Can... Recurrent Adeno... Recurrent Basal... Recurrent Breas... Recurrent Colon... Recurrent Esthe... Recurrent Gastr... Recurrent Inver... Recurrent Lymph... Recurrent Lymph... Recurrent Melan... Recurrent Metas... Recurrent Midli... Recurrent Mucoe... Recurrent Ovari... Recurrent Prost... Recurrent Renal... Recurrent Saliv... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Verru... Recurrent Verru... Stage III Adeno... Stage III Basal... Stage III Colon... Stage III Esthe... Stage III Gastr... Stage III Inver... Stage III Lymph... Stage III Lymph... Stage III Melan... Stage III Midli... Stage III Mucoe... Stage III Ovari... Stage III Renal... Stage III Saliv... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Verru... Stage III Verru... Stage IIIB Brea... Stage IIIC Brea... Stage IV Adenoi... Stage IV Basal ... Stage IV Breast... Stage IV Colon ... Stage IV Esthes... Stage IV Gastri... Stage IV Invert... Stage IV Lympho... Stage IV Lympho... Stage IV Melano... Stage IV Midlin... Stage IV Mucoep... Stage IV Ovaria... Stage IV Prosta... Stage IV Renal ... Stage IV Saliva... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Verruc... Stage IV Verruc... Unspecified Adu... Untreated Metas... | alvespimycin hy... laboratory biom... pharmacological... | 18 Years - | National Cancer Institute (NCI) | |
Growth Factor Levels in the Blood of Patients Undergoing Radiation Therapy for Epithelial Cancer | NCT00897793 | Breast Cancer Colorectal Canc... Head and Neck C... Lung Cancer Prostate Cancer | venipuncture radiation thera... | 18 Years - | Vanderbilt-Ingram Cancer Center | |
Combination Chemotherapy and Radiation Therapy in Treating Patients With Colorectal Cancer | NCT00002801 | Colorectal Canc... | leucovorin calc... tegafur-uracil radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
Perioperative Chemotherapy in Treating Patients With Colon Cancer That Can Be Surgically Removed | NCT00002525 | Colorectal Canc... | fluorouracil leucovorin calc... | 18 Years - | Eastern Cooperative Oncology Group | |
Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer | NCT00003594 | Colorectal Canc... | irinotecan fluorouracil leucovorin calc... oxaliplatin | 18 Years - | Alliance for Clinical Trials in Oncology | |
Biological Therapy With Combination Chemotherapy in Patients With Colorectal Cancer | NCT00003063 | Colorectal Canc... | recombinant int... fluorouracil leucovorin calc... levamisole hydr... | - 75 Years | National Cancer Institute (NCI) | |
LMB-9 Immunotoxin in Treating Patients With Advanced Pancreatic, Esophageal, Stomach, Colon, or Rectal Cancer | NCT00010270 | Colorectal Canc... Esophageal Canc... Gastric Cancer Pancreatic Canc... | LMB-9 immunotox... | 18 Years - | National Cancer Institute (NCI) | |
DJ-927 as Second-Line Therapy in Treating Patients With Progressive Locally Advanced or Metastatic Colorectal Adenocarcinoma | NCT00080834 | Colorectal Canc... | DJ-927 | 18 Years - | Daiichi Sankyo | |
Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract | NCT00012246 | Colorectal Canc... Esophageal Canc... Extrahepatic Bi... Gallbladder Can... Gastric Cancer Pancreatic Canc... Small Intestine... | carcinoembryoni... incomplete Freu... sargramostim | 18 Years - | The University of Texas Medical Branch, Galveston | |
Irinotecan and Capecitabine in Treating Patients With Solid Tumors | NCT00003867 | Cancer | capecitabine irinotecan hydr... | 18 Years - 120 Years | Montefiore Medical Center | |
Perioperative Chemotherapy in Treating Patients With Colon Cancer That Can Be Surgically Removed | NCT00002525 | Colorectal Canc... | fluorouracil leucovorin calc... | 18 Years - | Eastern Cooperative Oncology Group | |
S-1 and Bevacizumab in Treating Patients With Colorectal Cancer That is Recurrent or Cannot Be Removed by Surgery | NCT00974389 | Colorectal Canc... | bevacizumab tegafur-gimerac... | 20 Years - 80 Years | National Cancer Institute (NCI) | |
Epothilone D as Second-Line Treatment for Patients With Advanced or Metastatic Refractory Colorectal Cancer | NCT00077259 | Colorectal Canc... | epothilone D | 18 Years - | Memorial Sloan Kettering Cancer Center | |
DJ-927 as Second-Line Therapy in Treating Patients With Progressive Locally Advanced or Metastatic Colorectal Adenocarcinoma | NCT00080834 | Colorectal Canc... | DJ-927 | 18 Years - | Daiichi Sankyo | |
Skin Biopsies and DNA Analysis in Patients Receiving Irinotecan or Gemcitabine For Advanced Solid Tumors | NCT00369109 | Breast Cancer Colorectal Canc... Pancreatic Canc... | biologic sample... immunohistochem... laboratory biom... biopsy | 18 Years - | Barbara Ann Karmanos Cancer Institute | |
Fluorouracil, Semustine, and Vincristine Compared With BCG in Treating Patients With Dukes' B or Dukes' C Colon Cancer That Has Been Removed By Surgery | NCT00427570 | Colorectal Canc... | BCG vaccine biological ther... fluorouracil semustine vincristine sul... | - 79 Years | National Cancer Institute (NCI) | |
Genetic Study in Patients With Stage II or Stage III Colon Cancer | NCT00003833 | Colorectal Canc... | DNA stability a... gene mapping | - 69 Years | Alliance for Clinical Trials in Oncology | |
Prognostic Value of the Immunoscore® Colon Test for Disease Free Survival Stratification in Stage III Patients Under Oxaliplatin Treatment | NCT03422601 | Colorectal Canc... Stage III Colon... | Immunoscore tes... | 18 Years - | GERCOR - Multidisciplinary Oncology Cooperative Group | |
Laparoscopic-Assisted Surgery Compared With Open Surgery in Treating Patients With Colon Cancer | NCT00002575 | Colorectal Canc... | conventional su... laparoscopic su... | 18 Years - | Alliance for Clinical Trials in Oncology | |
Genetic Study of Familial Factors in Patients With Colon Cancer | NCT00055848 | Colorectal Canc... | cytogenetic ana... gene mapping microarray anal... | - 70 Years | Alliance for Clinical Trials in Oncology | |
Lymphatic Mapping, Sentinel Lymph Node Analysis, and Blood Tests in Detecting and Predicting Early Micrometastases in Patients With Colorectal Cancer | NCT00625625 | Colorectal Canc... | isosulfan blue polymerase chai... diagnostic labo... immunohistochem... diagnostic lymp... therapeutic con... therapeutic lym... | 18 Years - | National Cancer Institute (NCI) | |
MRI in Predicting Response in Patients Receiving Combination Chemotherapy and Bevacizumab For Advanced or Metastatic Colorectal Cancer | NCT00602329 | Colorectal Canc... | bevacizumab fluorouracil leucovorin calc... oxaliplatin | 18 Years - 120 Years | Abramson Cancer Center at Penn Medicine | |
Palliative Chemotherapy in Treating Patients With Advanced Colorectal Cancer | NCT00002893 | Colorectal Canc... | fluorouracil leucovorin calc... raltitrexed | - | National Cancer Institute (NCI) | |
Cetuximab and Simvastatin in Treating Patients With Advanced or Metastatic Colorectal Cancer | NCT01190462 | Colorectal Canc... | cetuximab simvastatin laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC) | NCT01126346 | Advanced Malign... Carcinoma of th... Ovarian Sarcoma Ovarian Stromal... Pseudomyxoma Pe... Recurrent Colon... Recurrent Malig... Recurrent Ovari... Recurrent Ovari... Stage III Colon... Stage III Ovari... Stage III Ovari... Stage IV Colon ... Stage IV Ovaria... Stage IV Ovaria... Unspecified Chi... | HIPEC Orientati... Consultation wi... Questionnaires | - | Wake Forest University Health Sciences | |
Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy | NCT01099449 | Chemotherapeuti... Colorectal Canc... Neuropathy Neurotoxicity | calcium glucona... magnesium sulfa... placebo oxaliplatin | 18 Years - | Alliance for Clinical Trials in Oncology | |
Patient-Reported Outcomes in Long-Term Survivors of Colon and Rectal Cancers | NCT00410579 | Colorectal Canc... Fatigue Long-term Effec... Pain Psychosocial Ef... | Telephone inter... | - | NSABP Foundation Inc |